3 Einträge gefunden

1. Guselkumab improves work productivity in patients with moderate-to-severe psoriasis with or without depression and anxiety: results from the VOYAGE 2 comparator study versus adalimumab

   1. Reich, Kristian
   2. Foley, Peter
   3. Han, Chenglong
   4. McElligott, Sean
   5. Muser, Erik
   6. Li, Nan
   7. Armstrong, April W

   2020 - Forschungsinformationssystem des UKE
2. Maintenance of Response Through up to 4 Years of Continuous Guselkumab Treatment of Psoriasis in the VOYAGE 2 Phase 3 Study

   1. Reich, Kristian
   2. Armstrong, April W
   3. Foley, Peter
   4. Song, Michael
   5. Miller, Megan
   6. Shen, Y K
   7. You, Yin

   2020 - Forschungsinformationssystem des UKE
3. Guselkumab Efficacy after Withdrawal Is Associated with Suppression of Serum IL-23-Regulated IL-17 and IL-22 in Psoriasis: VOYAGE 2 Study

   1. Gordon, Kenneth B
   2. Armstrong, April W
   3. Foley, Peter
   4. Song, Michael
   5. Shen, Yaung-Kaung
   6. Li, Shu
   7. Muñoz-Elías, Ernesto J

   2019 - Forschungsinformationssystem des UKE